EAU 2013 - Programme Book - YouMed

Monday, 18 March - EAU Programme
Abstract Session
09.15 - 10.45 OAB in women
Blue Hall 1-2 - Level N1
Poster Session 64
Chairs: P. Dinis Oliveira, Porto (PT)
T. Hanus, Prague (CZ)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
* 775 Sacral Nerve Stimulation (SNS) for the treatment of idiopathic refractory overactive bladder: Costeffectiveness
compared to optimal medical therapy, botulinum toxin A (BoNT-A) and percutaneous tibial
nerve stimulation (PTNS)
J. Jenks, R. Hamid, P.J.R. Shah, T.J. Greenwell, C. Betts, S. Walleser, N. Hallas, J.L. Ockrim (London, Salford,
United Kingdom; Tolochenaz, Switzerland)
776 Tined lead versus percutaneous nerve evaluation for sacral nerve stimulator assessment
J. Jenks, R. Hamid, P.J.R. Shah, T.J. Greenwell, J.L. Ockrim (London, United Kingdom)
777 Affect on bowel symptoms in patients having sacral neuromodulation for detrusor overactivity
A. Gulamhusein, J. Fielding, R. Simmons, S.V. Reid (Sheffield, United Kingdom)
778 Transcutaneous posterior tibial nerve stimulation: Evaluation of therapeutic option in overactive bladder
syndrom
M. Ammi, P. Bigot, D. Chautard, S. Larre, T. Culty, C. Pinon, A. Azzouzi (Angers, France)
779 Objective efficacy of mirabegron on storage and voiding function in patients with overactive bladder,
based on a urodynamic study
Y. Matsukawa, Y. Funahashi, S. Takai, Y. Yoshino, T. Yamamoto, M. Gotoh (Nagoya, Japan)
* 780 Overactive bladder syndrome in elderly: Is there a place for detrusor Botox injections?
V.M. Keppenne, D. Waltregny, S. Sanjurjo (Liege, Belgium)
781 Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A
injections in detrusor overactivity
R. Veeratterapillay, C. Harding, N. Vasdev, L. Teo, A. Abroaf, R. Pickard, T. Dorkin, T. Hasan, A. Thorpe
(Newcastle upon Tyne, United Kingdom)
782 The effect of solifenacin on bladder wall thickness in women with overactive bladder and detrusor
overactivity: Results from the SHRINK study
D. Robinson, M. Oelke, R. Tretter, B. Stow, G. Compion, A. Tubaro (London, Chertsey, United Kingdom;
Hanover, Germany; Leiderdorp, The Netherlands; Rome, Italy)
783 Single surgeon experience of clam ileocystoplasty for refractory idiopathic detrusor overactivity
S. Pisipati, F. Khan, R.B. Kinder (Cheltenham, United Kingdom)
784 The characteristics and prognosis for impaired detrusor contractility in non-geriatric patients
C-W. Yang, Y-H. Fan, C-C. Lin, J.S. Huang, T.L. Ling, K-K. Chen (Taipei, Taiwan)
EAU Milan 2013
251
Monday